Julia Aijun Wang

Insider Reports History

Location
Burlington, NC
Signature
/s/ Kathryn W. Kyle, Attorney-in-Fact for Julia Aijun Wang
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Julia Aijun Wang:

Form 4 holding Chief Financial Officer

BeiGene, Ltd.

Security class
Ordinary Shares
Shares / value
426,595
Estimated value
$88,611,076
Report date
01 Jul 2024
Price
$207.72
Ownership
Direct
Form 4 holding Chief Financial Officer, EVP

LABCORP HOLDINGS INC.

Security class
Restricted Stock Unit
Shares / value
4,964
Estimated value
$1,075,461
Report date
11 Feb 2026
Price
$246.27
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

BeiGene, Ltd.

Security class
American Depositary Shares
Shares / value
0
Estimated value
$0
Report date
01 Jul 2024
Price
$143.90
Ownership
Direct
Form 4 holding Chief Financial Officer

BeiGene, Ltd.

Security class
Share Option (Right to Buy)
Shares / value
256,659
Estimated value
Report date
05 Jun 2024
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding Chief Financial Officer, EVP

LABCORP HOLDINGS INC.

Security class
Non-qualified Stock Options
Shares / value
7,100
Estimated value
Report date
10 Feb 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Julia Aijun Wang

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .